(Press-News.org) A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.
RSV infects half of the infants in the world every year, and 1 percent to 2 percent of infected infants are hospitalized for severe disease.
The study, reported in the Journal of Clinical Investigation, identifies a specific sub-population of children who are more likely to be hospitalized because of RSV infection, said Fernando Polack, M.D., Cesar Milstein Professor of Pediatrics at Vanderbilt and senior author of the report.
The findings support further studies directed at understanding how these children respond to RSV infection and discovering strategies to reduce their risk of severe disease, said Polack, who also directs Fundación INFANT in Buenos Aires, Argentina.
"This sub-population of children contributes to a significant number of the hospitalizations due to RSV, which is not trivial," Polack said.
Polack and his colleagues studied two independent populations of infants with bronchiolitis to explore the hypothesis that interactions between the environment and genetic variants in TLR4 -- a receptor that activates the innate immune response -- modulate RSV disease severity.
They found that a particular genetic change in TLR4 was associated with more severe disease in children from urban middle-class families, but was associated with milder disease in children living in rural areas.
Urban children with the mutation were eight times more likely to be hospitalized with RSV infection compared to their neighbors without the mutation. Their risk for hospitalization may be similar to that for extremely premature babies, a highly vulnerable population for RSV disease.
The TLR4 mutation emerged as a protective variant at a time when humans had heavy exposure to environmental bacteria and other pathogens, Polack explained. It appears to play this protective role in children living on farms or in low-income populations in developing countries.
In cities with "clean water and a vacuum cleaner in every home, the mutation behaves completely differently," Polack said. Urban children with the mutation respond to RSV infection with an allergic response in the lungs. The children have high levels of the cytokine interleukin-4 and low levels of interferon-gamma in respiratory secretions, the researchers found.
Previous studies demonstrated that children with the TLR4 mutation -- about 10 percent of children in the United States -- may not be protected by palivizumab, the only medication approved to prevent RSV infections.
"Even in the context of receiving prophylactic treatment, these kids appear to end up hospitalized," Polack said.
With multiple RSV vaccine candidates in the pipeline, it will be important to monitor the response of children with the TLR4 mutation during vaccine trials, he said.
"This sub-population may or may not respond in the same way as children without the mutation," he said. "They are at risk of failing vaccination and still requiring hospitalization after RSV infection."
INFORMATION:
Vanderbilt professors R. Stokes Peebles, M.D., and Mark Boothby, M.D., Ph.D., participated in the studies. The research was supported by grants from the Bill & Melinda Gates Foundation and the National Institutes of Health (AI054952, AI104853).
With obesity on the rise in households across America, the demand for weight-loss treatments, personal trainers, and lifestyle coaches is amping up. But when it comes to physical fitness, the best incentive to get in shape might be the very person sitting across from you at the dinner table.
New research finds that exercising isn't only good for you - it is also good for your spouse. According to Dr. Silvia Koton of the Department of Nursing at Tel Aviv University's Sackler Faculty of Medicine, lead investigator Dr. Laura Cobb, and their colleagues at the Johns Hopkins ...
WASHINGTON --Abdominal pain, fever and unexplained bleeding - which are commonly believed to indicate infection with the Ebola virus -- are not significantly predictive of the disease, according to the results of a study examining a new Ebola Prediction Score published online Friday in Annals of Emergency Medicine ("Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients with Suspected Ebola Virus Disease").
"Not surprisingly, contact with a suspected or confirmed Ebola patient was the strongest independent predictor of having ...
Single women seeking treatment with donor semen do not differ from cohabiting women seeking treatment with regard to sociodemographic characteristics or attitudes toward motherhood, a new study of 311 Danish women shows. For most, to be a single mother by choice is not their preferred way of parenthood, but rather a solution they need to accept as they get older.
The findings may help dispel the myth that single women are in anyway less suited to motherhood than those who live with a spouse.
"Various family formations are a normal part of the Danish society, but data ...
The term "sarcopenia" is most often used to describe age-related loss in muscle mass and strength, and it is commonly considered analogous to osteoporosis. Yet unlike osteoporosis, which can be diagnosed based on widely accepted clinical criteria, sarcopenia is not recognized as a clinical condition even though it can impair physical function and contribute to disability, falls, and hospitalizations.
A new review addresses this concern and points to efforts aimed at developing and refining sarcopenia criteria.
"For over 20 years, the lack of a consensus definition ...
The use of asbestos continues to increase in Asia despite clear health hazards. A recent Respirology review notes that with approximately 4.3 billion people and a growing population, Asia will likely see a large crop of asbestos-related lung diseases in the next few decades. Some of the cases will be benign, but it is likely that there will be many cases of mesothelioma and lung cancer.
Efforts are needed to improve the recognition and diagnosis of asbestos-related lung diseases, and government and non-government groups must cooperate to take steps to prevent them.
INFORMATION: ...
The number of individuals enrolled in both Medicare Advantage (MA) and the Veterans Affairs (VA) health system nearly doubled from 2004 to 2009, and such dual enrollees are expected to increase in number following the full implementation of the Affordable Care Act. Because both the VA and MA are federally funded managed care systems, expenditures are duplicated for individuals who are dually enrolled.
A new Health Services Research study has found that while dual use does not appear to erode quality of care, there's also no evidence that it improves it.
INFORMATION: ...
The fixed combination of the drugs tafluprost and timolol (trade name: Taptiqom) has been approved in Germany since December 2014 for adults with open-angle glaucoma or increased intraocular pressure (ocular hypertension). The combination therapy is indicated in patients who are insufficiently responsive to topical monotherapy with beta-blockers or prostaglandin analogues, and who would benefit from preservative-free eye drops.
The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug combination offers an ...
We age in part thanks to "friendly fire" from the immune system -- inflammation and chemically active molecules called reactive oxygen species that help fight infection, but also wreak molecular havoc over time, contributing to frailty, disability and disease. The CD33rSiglec family of proteins are known to help protect our cells from becoming inflammatory collateral damage, prompting researchers at the University of California, San Diego School of Medicine to ask whether CD33rSiglecs might help mammals live longer, too.
In a study published April 7 by eLife, the team ...
Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester and NatCen Social Research.
Drugs, clinically known as oral phosphodiesterase type 5 inhibitors (PDE5i), have become the first-line medical treatment option for sufferers of erectile dysfunction (ED) - also known as impotence - since entering the UK market in 1998.
An abundance of studies has demonstrated the effectiveness of such drugs. But researchers at The University of Manchester, who have studied the responses of more than 2,600 ...
Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer. They demonstrate that the signaling pathway can be blocked using compounds that are already in clinical development. This finding might be extremely important for the diagnosis, prognosis and treatment of this disease in the future.
Diffuse large B-cell lymphoma (DLBCL) is a blood cancer and the most common malignant condition of the lymphatic system. Although DLBCL is always fatal if left untreated, the cure rate after chemo-therapy ...
